发明公开
- 专利标题： AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES
- 专利标题（中）： 氨基磺酰胺咪唑吡嗪
-
申请号： EP12806400.3申请日： 2012-12-10
-
公开(公告)号： EP2804864A1公开(公告)日： 2014-11-26
- 发明人: EIS, Knut , PÜHLER, Florian , ZORN, Ludwig , LIENAU, Philip , SUELZLE, Detlev , HÄGEBARTH, Andrea , BÖMER, Ulf , PETERSEN, Kirstin , SCHULZE, Volker
- 申请人： Bayer Intellectual Property GmbH
- 申请人地址： Alfred-Nobel-Strasse 10 40789 Monheim DE
- 专利权人： Bayer Intellectual Property GmbH
- 当前专利权人： Bayer Intellectual Property GmbH
- 当前专利权人地址： Alfred-Nobel-Strasse 10 40789 Monheim DE
- 代理机构： BIP Patents
- 优先权： EP11193004 20111212; EP12191774 20121108
- 国际公布： WO2013087581 20130620
- 主分类号： C07D491/048
- IPC分类号： C07D491/048 ; A61K31/5025 ; A61P35/00
摘要：
The present invention relates to amino-substituted imidazopyndazine compounds of general formula (I) : in which A, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
公开/授权文献
- EP2804864B1 AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES 公开/授权日：2017-09-06
信息查询
